Quintessence Biosciences' Unattributed - II Round

Quintessence Biosciences raised a round of funding on October 07, 2011.

Quintessence Biosciences is a biopharmaceutical company focused on development of-based therapeutics as anti-cancer agents. The Company's products are based on the EVade Ribonuclease Technology which …

Articles about Quintessence Biosciences' Unattributed - II Round: